Doctors and Scientists Write to European Medicines Agency Warning of COVID-19 Vaccine Dangers

}

A group of scientists and doctors on the 1st of March, 2021 have issued an open letter calling on the European Medicines Agency (EMA) to answer urgent safety questions regarding COVID-19 vaccines, or withdraw the vaccines’ authorisation.
The letter describes serious potential consequences of COVID-19 vaccine technology, warning of possible autoimmune reactions, blood clotting abnormalities, stroke and internal bleeding, “including in the brain, spinal cord and heart”. The authors request evidence that each medical danger outlined “was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.”

“Should all such evidence not be available”, the authors write, “we demand that approval for use of the gene-based vaccines be withdrawn until all the above issues have been properly addressed by the exercise of due diligence by the EMA.”

The letter is addressed to Emer Cooke, Executive Director of the EMA, and was sent on Monday 1 March 2021. The letter was copied to the President of the Council of Europe and the President of the European Commission.

It states: “We are supportive in principle of the use of new medical interventions.” However, “there are serious concerns, including but not confined to those outlined above, that the approval of the COVID-19 vaccines by the EMA was premature and reckless, and that the administration of the vaccines constituted and still does constitute ‘human experimentation’, which was and still is in violation of the Nuremberg Code.”

Link to letter: Doctors for Covid Ethics

Video statement by Professor Sucharit Bhakdi, Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene:

https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0

For comment contact Professor Sucharit Bhakdi MD: [email protected],

or Associate Professor Michael Palmer MD: [email protected]

In a public statement the group said…

“No sooner did we deliver our letter than the Norwegian Medicines Agency warned that COVID-19 vaccines may be too risky for use in the frail elderly, the very group these vaccines are designed to protect. We would add that, by virtue of the mechanisms of action of the vaccines, to stimulate the production of spike protein, which has adverse pathophysiological properties, there may also be vulnerable people who are not old and already ill.

New data shows that vaccine side effects are three times as common in those who have previously been infected with coronavirus, for example. None of the vaccines have undergone clinical testing for more than a few months, which is simply too short for establishing safety and efficacy.

“Therefore, as a starting point, we believe it is important to enumerate and evaluate all deaths which have occurred within 28 days of vaccination, and to compare the clinical pictures with those who have not been vaccinated.

“Under Resolution 2361, member states must also inform citizens that vaccination is NOT mandatory and ensure that no one is politically, socially, or otherwise pressured to become vaccinated.''

Find me on Gab @Evolve_to_Ecology

Related Articles on my Wordpress blog

Dr Fuellmich begins global lawsuits on governments worldwide for COVID 19 fraud, this is dubbed the 2nd Nuremberg trial

World Renowned Scientist used Bayesian analysis on SARS-CoV-2 to find it is of Lab Origin

Covid-19: politicisation, “corruption,” and suppression of science

Lockdowns and Business Closure Found to be Scientifically Proven Ineffective

A Recipe for Next Generation Warfare

22 Scientists Debunked the Science behind PCR test accuracy

Dr Kory recommends Ivermectin, a powerful anti-viral drug for early treatment for COVID Patients

Hydroxychloroquine treatment for Covid-19 patients

Fauci’s National Institute of Allergy funds $7.4 million to the Wuhan Institute of Virology lab

Dr. Fauci Backed Controversial Wuhan Lab with U.S. Dollars for Risky Coronavirus Research